Related Articles
New aromatase inhibitors in the treatment of advanced breast cancer.
New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS
Growth inhibitory efficacy and anti‑aromatase activity of Tabebuia avellanedae in a model for post‑menopausal Luminal A breast cancer
Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells